Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pharma’s Blame-The-Middleman Strategy Pays Off – For Now

16 May 2018

• By Michael McCaughan

Related Content

Trump Drug Pricing Plan Includes Part D Surprises, Challenges PBM Business Model

12 May 2018

Part B Drugs Could Be Switched To Part D Under Trump Pricing Plan

15 May 2018

Breaking 340B: What Happens After Medicare Payment Cut?

12 Jan 2018

Opioid Manufacturers Should Prepare For A Tobacco Moment

05 May 2018

Additional Topics

United States Pricing Debate Policy BioPharmaceutical

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.